Last updated 2026-06-18
- Raised $20M funding round, Jun 2020
- Raised $10M funding round, Nov 2018
- Raised $10M funding round, May 2015
Total raised
$42.5M
Last: 2020-06
Stage
Series A
Founded
2008
Headcount
62
HQ
Ness Ziona, Israel
Sector
Health Tech & Life Sciences
About
Mapi Pharma is a clinical-stage pharmaceutical company developing proprietary pharmaceuticals, including lifecycle management products such as Depot long-acting injections, complex active pharmaceutical ingredients, and formulations.
The company’s lead product is Glatiramer Acetate Depot, a once-monthly injection for the treatment of patients with multiple sclerosis. Mapi is also engaged in the development of Pregabalin ER for the treatment of neuropathic pain and epilepsy, Paliperidone Palmitate and Buspirone ER for the treatment of schizophrenia, and other long-acting Depot injectable treatments.
Funding history · 4 rounds · $42.5M total
2020-06
$20.0M
2019-03
Grant
$2.5M
2018-11
$10.0M
2015-05
$10.0M
Q&A
- What is Mapi Pharma's primary focus?
- Mapi Pharma is a clinical-stage pharmaceutical company focused on developing proprietary pharmaceuticals, including lifecycle management products such as Depot long-acting injections, complex active pharmaceutical ingredients, and formulations.
- What is Mapi Pharma's lead product?
- Mapi Pharma's lead product is Glatiramer Acetate Depot, a once-monthly injection designed for the treatment of multiple sclerosis.
- What other products is Mapi Pharma developing?
- Mapi Pharma is also developing Pregabalin ER for neuropathic pain and epilepsy, Paliperidone Palmitate and Buspirone ER for schizophrenia, and other long-acting Depot injectable treatments.
- When was Mapi Pharma founded?
- Mapi Pharma was founded in January 2008.
- Where is Mapi Pharma headquartered?
- Mapi Pharma is headquartered in Ness Ziona, Center District, Israel.
- How many employees does Mapi Pharma have?
- Mapi Pharma has 51–200 employees.
- What is the total amount of funding Mapi Pharma has raised?
- Mapi Pharma has raised a total of $42,500,000 USD.
- When was Mapi Pharma's most recent funding round and who participated?
- Mapi Pharma's most recent funding round occurred in June 2020, with Mylan participating.
- Who is the founder of Mapi Pharma?
- Ehud Marom is the Founder, Chairman & CEO of Mapi Pharma.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
pain-reliefpharmaceuticalsdiabetesgeneric-drugsepilepsyschizophreniainflammatory-diseasespharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | mapi-pharma.com |
|---|---|
| linkedin.com/company/5229663 | |
| YouTube | youtube.com/channel/UCX1qdf5rKzaWtsUwJ_dxFVQ |
| Wikidata | wikidata.org/wiki/Q104481086 |
Identifiers & details
| Founded | 2008-1 |
|---|---|
| Employees (exact) | 62 |
| Offices | Nanjing |
| Wikidata QID | Q104481086 |
Radar intelligence
Patents
| EPO | 52 |
|---|
Web history (Wayback)
| Domain | mapi-pharma.com |
|---|
Wikidata
| QID | Q104481086 |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|